Your browser doesn't support javascript.
loading
TERT Promoter Mutation in Serum Cell-Free DNA Is a Diagnostic Marker of Primary Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease.
Akuta, Norio; Kawamura, Yusuke; Kobayashi, Mariko; Arase, Yasuji; Saitoh, Satoshi; Fujiyama, Shunichiro; Sezaki, Hitomi; Hosaka, Tetsuya; Kobayashi, Masahiro; Suzuki, Yoshiyuki; Suzuki, Fumitaka; Ikeda, Kenji; Kumada, Hiromitsu.
Affiliation
  • Akuta N; Department of Hepatology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan, norioakuta@toranomon.gr.jp.
  • Kawamura Y; Department of Hepatology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
  • Kobayashi M; Liver Research Laboratory, Toranomon Hospital, Tokyo, Japan.
  • Arase Y; Department of Hepatology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
  • Saitoh S; Department of Hepatology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
  • Fujiyama S; Department of Hepatology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
  • Sezaki H; Department of Hepatology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
  • Hosaka T; Department of Hepatology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
  • Kobayashi M; Department of Hepatology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
  • Suzuki Y; Department of Hepatology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
  • Suzuki F; Department of Hepatology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
  • Ikeda K; Department of Hepatology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
  • Kumada H; Department of Hepatology, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
Oncology ; 99(2): 114-123, 2021.
Article in En | MEDLINE | ID: mdl-32998139

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Telomerase / Non-alcoholic Fatty Liver Disease / Cell-Free Nucleic Acids / Liver Neoplasms / Mutation Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Oncology Year: 2021 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Telomerase / Non-alcoholic Fatty Liver Disease / Cell-Free Nucleic Acids / Liver Neoplasms / Mutation Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Oncology Year: 2021 Type: Article